CD207 and neoplasm: The inhibition of tumor growth by epicutaneous immunization with low-dose antigen was completely abrogated in the Langerin-DTR mice depleted for Langerin+ DC, whereas application of a higher dose of antigen still partly inhibited tumor growth even in the absence of Langerin+ DC (153).